{"id":"W4399700057","doi":"10.1016/j.jval.2024.03.616","title":"EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Alberta; AstraZeneca (Canada)","funders":"","keywords":"Germline; Oncology; Olaparib; Human Epidermal Growth Factor Receptor 2; Adjuvant; Medicine; Breast cancer; Germline mutation; Perspective (graphical); Internal medicine; Cancer research; Cancer; Gynecology; Mutation; Biology; Genetics; Gene; Computer science; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004142125,0.0009300821,0.001316088,0.001782889,0.0009953063,0.004117751,0.00152842,0.002103368,0.007567509],"category_scores_gemma":[0.01460465,0.0003349428,0.002017626,0.003117551,0.00106529,0.0007489624,0.0007845392,0.00268502,0.0003183663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08107064,"about_ca_system_score_gemma":0.1142154,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9498653,"about_ca_topic_score_gemma":0.9630023,"domain_scores_codex":[0.996919,0.001065406,0.0001441806,0.0001478264,0.001026614,0.0006970153],"domain_scores_gemma":[0.9927297,0.002225321,0.0005528711,0.00008292889,0.0029972,0.001411958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01791828,0.0008338764,0.04125002,0.008423066,0.009042695,0.001023666,0.0005710166,0.1280551,0.002205711,0.1212024,0.2322116,0.4372627],"study_design_scores_gemma":[0.01355996,0.003490676,0.2850225,0.02636938,0.02233689,0.001569688,0.003219677,0.1000369,0.002235953,0.07367154,0.4673193,0.001167433],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1537099,0.3468463,0.003429334,0.2959104,0.002490865,0.0004622116,0.03733352,0.0001355691,0.1596819],"genre_scores_gemma":[0.8502178,0.1128002,0.003896162,0.01329359,0.001361532,0.0001412017,0.006422467,0.00007445095,0.01179258],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.08107064,"threshold_uncertainty_score":0.5882114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2185593523519791,"score_gpt":0.4178131281998663,"score_spread":0.1992537758478872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}